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Summary.-Lymphocytes infiltrating human primary mammary carcinomas lack
ADCC and show low levels ofnatural cytotoxicity. The peripheral blood lymphocytes,
however, show a variable but prominent level of cytotoxicity. Lymphocyte prepara-
tions from breast tumours, when mixed with autologous blood lymphocytes,
significantly suppress their prominent killer- (K- and NK-) cell activities.
VARIOUS ANTI-TUMOUR host-defence
mechanisms have been postulated to
operate in man, and in particular the
possible beneficial role of lymphocytic
killer cells has been invoked (Cerottini &
Brunner, 1974; Henney, 1977; Herberman
& Holden, 1979). A possible explanation
for the improved survival and reduced
potential to metastasize, seen with exten-
sive lymphocytic infiltrates of primary
tumours (for review see Underwood,
1974), is the in situ tumour cell damage
mediated by the infiltrating killer lympho-
cytes.
The presence of a prominent lympho-
cytic infiltrate within mammary carcino-
mas has been found by many investigators
to be a favourable prognostic sign (Moore
& Foote, 1948; Berg, 1959; Anastassiades
& Pryce, 1966; Hamlin, 1968; Cutler
et al., 1969; Di Paola et al., 1974; Fisher
et al., 1975). The precise anti-tumour role
of the tumour-infiltrating lymphocytes,
however, is asyetimproperly understood.
We have previously described antibody-
dependent cellular-cytotoxicity (ADCC)
mediated by killer (K) cells, and natural
cytotoxicity mediated by natural killer
(NK) cells, in the peripheral blood and
regional tumour-draining lymph nodes of
patients with mammary carcinoma, clinic-
ally localized to the breast and axilla
(Eremin et al., 1977a; 1978a). In this
communication we report our findings on
the K and NK activity of lymphocytes
isolated from the primary mammary car-
cinomas removed at operation from such
patients.
METHODS
Blood lymphocyte preparation
Venous blood, from healthy adult volun-
teers and patients with breast cancer, was
collected by venepuncture into syringes con-
taining preservative-free heparin (30 i.u./ml).
The patients were women, aged 40-67 years,
with a clinical Stage I or II mammary car-
cinoma confined to the breast and axilla.
Lymphocytes were isolated from the heaprin-
ized blood on a Ficoll-Hypaque gradient,
washed and made up in tissue-culture medium
(TCM). TCM consisted of RPMI 1640 with
10% heat-inactivated foetal calf serum,
(0 7 gIl) streptomycin (100 jtg/l) and penicillin
G (100,000 i.u./l).
To assess the effect ofthe various methodo-
logical procedures on K and NK activity,
some of the blood lymphocytes were further
treated as follows: (a) 107 lymphocytes were
incubated with 15 ml of collagenase (Sigma,
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Type 1-see below) at 37°C for varying
periods of time (1-24 h). (b) 3 x 107 lympho-
cytes were passaged down Sephadex G-10
columns (see below) and the emerging cells
collected from the eluate. After both treat-
ments the cells were washed x 3 in TCM,
counted and viability reassessed.
Tumour-infiltrating lymphocyte preparation
Mechanical disaggregation.-The breast-
tumour specimen was obtained in a sterile
manner at operation from the excisional
biopsy sample sent for frozen section. The
tumour specimen was cleared offat and fascia
and washed in TCM. The specimen was then
carefully sliced (Size 10 scalpel blades) into
small, thin slices, in a small pot filled with
TCM. Spill-out of cells occurred during this
procedure. The cell-enriched supernatant
was removed, filtered through sterile gauze
layers to remove residual stromal fragments
and then washed x 5 in TCM. This technique
usually produced a low yield of viable cells
and a substantial number of necrotic cells
which often had to be removed by layering on
a Ficoll-Hypaque gradient (sp. gr. 1-077) and
centrifuging at 400 g for 15 min.
Enzymatic digestion.-The small, chopped-
up pieces were then incubated in collagenase
(Sigma, Type 1) at 37°C for 11-14 h. (The
collagenase, 300 u./ml, was dissolved in TCM
(protein-free), filter-sterilized and stored at
-30°C.) The prolonged incubation of the
tumour pieces produced a thick cell suspen-
sion, which was washed x 6 with TCM and
passed through sterile gauze layers to remove
residual stromal fragments and debris. This
procedure usually yielded a substantial num-
ber of viable cells (5-50 x 106) depending
primarily on the size of the tumour specimen
processed. The lymphocytes, consisting of a
variable percentage of the total cell yield,
were isolated from such enzyme preparations
by passage on Sephadex G-10 columns (see
below). Lymphocyte numbers, viability and
contamination bymacrophages was reassessed
in the column eluate. Occasionally there was a
heavy contamination by red blood cells,
which were removed by lysis with deionized
water-a procedure known not to reduce
killer-cell activity (Eremin et al., 1978b).
Cell size and viability were assessed by
phase-contrast microscopy. Surface-marker
characteristics were determined by various
resetting assays and the data presented in
Eremin et al. (submitted). Where possible,
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morphology was characterized further by
stained smears or cytocentrifuge preparations.
Sephadex G-10 columns
Sephadex G-10 columns, as described pre-
viously (Eremin et al., 1980b; Kanski et al.,
1981) were used to isolate lymphocytes from
enzymatically digested tumour-cell prepara-
tions, the much larger macrophages and
tumour cells being trapped on the column.
This procedure has been found not to deplete
selectively different lymphocyte subsets,
irrespective of the source ofthe lymphocytes.
Cytotoxicity assays
ADCC was determined by an in vitro 3h,
51Cr-release assay as previously described
(Eremin et al., 1977a). The target cells used
were CLA4, a lymphoblastoid cellline growing
as a suspension culture (Epstein-Barr-virus
positive) and Detroit 6 (D6), growing as a
monolayer (Eremin et al., 1977a). The target
cells were coatedwith humananti-HLA serum
(1:500) or with rat IgG anti-D6 antibody
(1:400). Effector cells were blood lympho-
cytes (normal, collagenase-treated and Sepha-
dex G-10 passaged), total-cell preparations
from breast tumours (mechanical disaggrega-
tion and collagenase digestion), lymphocytes
isolated from breast-tumour preparations
(collagenase digestion and Sephadex G-10
passage, mechanical disaggregation) and lym-
phocytesisolatedfrombreast-tumourprepara-
tions (collagenase digestion and Sephadex
G-10 passage) and depleted ofT lymphocytes.
The effector:target-cell ratio was 40:1, 20:1
and 0:1.
Natural cytotoxicity was determined by an
in vitro, 24h, 51Cr-release assay as described
by Eremin et al. (1978a). The target cells were
CLA4 and D6, and the effector cells were as
outlined above.
Percentage isotope released was calculated,
and assays were statistically evaluated by
analysis of variance on the logarithm of the
percentage isotope released. Duncan's mul-
tiple-range testing was used to assess the
significance of the various treatments on
ADCC and NK cytotoxicity.
Lymphocyte surface markers
Lymphocyte surface markers were deter-
mined by various rosetting assays. The thy-
mus-derived E-rosetting lymphocytes were
enumerated as described by Eremin et al.
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(1976). Briefly, sheep red blood cells (1%
suspension) were rosetted with lymphocytes
(2 x 106/ml) in the presence of 30% foetal
calf serum (absorbed with SRBC), by centri-
fuging at 200 g for 3 min and allowing to
stand for 1 h at room temperature. The
slg-bearing B lymphocytes were detected by
the direct antiglobulin rosetting (DAR)
assay, using chromic chloride to couple the
rabbit anti-human Fab to trypsin-treated ox
red blood cells (Coombs et al., 1977).
Surface-marker profiles were done on the
following preparations of tumour-infiltrating
lymphocytes: (1) lymphocytes isolated by
collagenase digestion and passage down
Sephadex G-10 columns; and (2) lymphocytes
isolated by collagenase digestion, passaged
down Sephadex G-10 columns anddepleted of
E-rosetting T lymphocytes.
T-lymphocyte depletion
Tumour-infiltrating lynmphocytes, isolated
by collagenase digestion and passage down a
Sephadex G-10 column, were rosetted in bulk
with SRBC (Eremin et al., 1976). The cell
mixture (rosetted T lymphocytes, non-roset-
ted lymphocytes and SRBC) was layered on
to a Ficoll-Hypaque gradient (sp. gr. 1.077)
and spun with an interface force of 400 g at
20°C for 15 min. After centrifugation, the
interface band of lymphocytes (free of con-
taminating SRBC) was removed, washed in
TCM and lymphocyte numbers and viability
reassessed. The efficacy of the depletion was
determined by rosetting. The untreated and
T-lymphocyte-depleted preparations were set
up in the 24h NK assay.
RESULTS
Blood lymphocyte preparations
Untreated.-Lymphocytes isolated from
the blood of patients with Stage I or II
mammary carcinoma (localized to the
breast and axilla) and from healthy con-
trols were 98% viable (phase contrast) and
free of contaminating phagocytic cells
(<1% polymorphs, < 30 monocytes).
Treated.-(a) Incubation of blood lym-
phocytes at 37°C with collagenase for
short periods (1-4 h) caused minimal cell
losses, but incubation for long periods
(16-24 h) led to substantial cell losses (30-
50%). The final cell suspensions, however,
were composed of viable lymphocytes
(95%0). (b) Passage of lymphocyte suspen-
sions down Sephadex G-I0 columnsyielded
a high percentage of viable cells (>80%0
recovery).
Tumour-infiltrating lymphocyte prepara-
tions
Mechanical disaggregation. A variable
but usually low yield ofviable cells (macro-
phages, tumour cells and lymphocytes) was
obtained by this technique. Usually most
of the cells were necrotic and a further
purification procedure, on a Ficoll-
Hypaque gradient, was then carried out.
Cell suspensions used in the killing assays
were either a mixture of lymphocytes
( - 50%) and other cell types (macro-
phages and tumour cells) or predominantly
lymphocytes (900%) as assessed morpho-
logically.
Enzymatic digestion.-Incubation with
collagenase yielded a substantially larger
number of viable cells (macrophages,
tumour cells and lymphocytes) from the
tumour specimens (5-50 x 106). The macro-
phages (10-60% of the non-lymphocytic
cells) expressed receptors for Fc(IgG) and
possessed surface immunoglobulin pre-
sumably acquired cytophilically. The
tumour cells (40-9000 of the non-lympho-
cytic cells) lacked receptors for Fc(IgG)
and were not coated with immunoglobulin.
The latter could not be detected even with
the very sensitive DAR assay (Coomb et
al., 1977). The tumour-infiltrating lympho-
cytes (10-50% of the total mononuclear
cell population, and in absolute terms
5x 105-22 x 106) were composed of both
T and B lymphocytes and their various
subsets (Eremin et al., submitted). In most
cases the tumour-infiltrating lymphocytes
were isolated from the tumour-cell pre-
parations by passage through Sephadex
G-10 columns. On average, 440/o (30-57%)
of the tumour-infiltrating lymphocytes
were recovered from the column, and on
average 85% (76-94%) ofthe mononuclear
cells eluted from the column were lympho-
cytes, the contaminants being > 70%/
macrophages.
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Most of the breast tumours were
scirrous and relatively avascular and the
very low erythrocyte:lymphocyte ratio
suggested minimal contaminationbyblood
elements.
Tumour -infiltrating lymphocyte prepara-
tions lack K-cell activity
Figs 1, 2 & 5 show the total absence of
ADCC in lymphocyte preparations ob-
tained from primary mammary carcino-
mas, which was seen whether target cells
were coated with human or rat IgG anti-
bodies. This total lack of K-cell activity
was seen in 14/16 breast-tumour speci-
mens (Fig. 5). In the remaining 2 speci-
mens there was a very low K-cell activity,
the breast-tumour preparation (before
column passage) being associated with a
relatively heavy contamination by RBC
and presumably by K cells, from the intra-
vascular compartment of the tumour.
Figs 1 & 2 show that enzymatically
obtained tumour-cell preparations (total-
cell suspensions from breast tumours),
even when not passaged down the Sepha-
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FIG. 1.-Tumour-infiltrating lymphocytes
lack K-cell activity when compared with
blood lymphocytes. ADCC assay: 51Cr-
labelled CLA4 target cells, coated with
human anti-HLA serum (1:500), incubated
at 37°C for 3 h with lymphocytes from:
(0) control blood; (A) tumour-bearer
blood; (*) tumour (collagenase digested);
(A) tumour (collagenase-digested, SG-10-
column-passaged); (LC:) tumour (mech-
anical disaggregation). A, B, C refer to
experiments with 3 different patients.
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Fia. 2.-As Fig. 1 but with different target
cells: 51Cr-labelled D6 cells, coated with
rat lgG anti-Det6 antibody (1:400), incu-
bated at 37°C for 3 h with the lymphocyte
suspensions described in Fig. 1.
dex G-10 column and containing both Fe
(IgG)-receptor-bearing macrophages and
lymphocytes, similarly lacked ADCC (4
specimens). Tumour-infiltrating lympho-
cytes, obtained by mechanical means (4
specimens), with or without Sephadex
G-10 column passage, also lacked K-cell
activity (Figs 1, 2 & 5). Prolonged
washing of the lymphocytes (up to 12 x )
failed to restore the K-cell activity (data
not shown); pre-incubating the lympho-
cytes at 37TC for 24 h also failed to restore
the absent ADCC (see Fig. 8). Longer
incubations (48-72 h) also failed to restore
the ADCC (data not shown).
Peripheral-blood lymphocyte prepara-
tions, on the other hand, from all the
patients tested showed a variable but
prominent K-cell activity (Figs 1, 2 &
5).
Tumour -infiltrating lymphocyte prepara-
tions show a low and significantly reduced
NK activity
The natural cytotoxicity oflymphocytes
isolated from primary breast tumours was
either low or totally lacking (Figs 3, 4 &
5). This pattern of NK activity was seen
(a) whether the method used to prepare
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Fia. 3.- Tumour-infiltrating lymphocytes
show a very low NK-cell activity against
CLA4 target cells as compared with blood
lymphocytes. Natural cytotoxicity assay-
51Cr-labelled CLA4 target cells incubated
at 37°C for 24 h with lymphocyte suspen-
sions prepared as described in Fig. 1.
(Symbols as in Fig. 1.)
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FIG. 4.-Tumour-infiltrating lymphocytes
show a low NK-cell activity against D6
target cells as compared with blood
lymphocytes. As in Fig. 3, using D6 target
cells.
and isolate the lymphocytes was mechani-
cal disaggregation or collagenase digestion
(Figs 3 & 4), (b) against both CLA4 and
D6 target cells (Figs 3 & 4) and (c) in all
the 15 patients investigated (Fig. 5). As
in the case ofthe K cell, prolonged washing
(up to 12 x), or pre-incubation at 37TC
before setting up the 24h in vitro assay,
Fim. 5. Diminished killer-cell (K and NK)
activity of 15 tumour-infiltrating lym-
phoid-cell preparations. ADCC assay 51Cr-
labelled CLA4 target cells, coated with anti-
HLA serum (1:500), incubated at 37°C for
3 h with lymphocytes from the patients'
blood and tumour.
Natural cytotoxicity assay 51Cr-
labelled CLA4 target cells incubated at
37°C for 24 h with lymphocytes from the
patients' blood and tumour.
Only maximal lymphocyte: target cell
ratio (40:1) shown. The percentage 51Cr
released was estimated by subtracting the
background release (targets alone) from the
maximal release.
failed to raise this low level of natural
cytotoxicity (Figs 9 & 10).
The peripheral-blood lymphocytes, on
the other hand, from all 15 patients
showed a variable but very prominent NK
activity (Fig. 5).
Incubation of blood lymphocytes with
collagenase didnotreduce Kand NKactivity
As can be seen from Fig. 6, pre-incuba-
tion of blood lymphocytes with collagen-
ase at 37°C for 4 h and 16 h did not reduce
ADCC nor NK cytotoxicity. Incubating
for more than 16 h (e.g. 24 h) on the other
hand did cause significant loss of lympho-
cytes, low cell viability and NK activities
(data not shown). All the breast-tumour
specimens were incubated with collagenase
for less than 16 h, and the cells from the
tumour digest for an even shorter period.
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FIG. 6. Pre-incubation of blood lympho-
cytes with collagenase does not reduce
ADCC or natural cytotoxicity. ADCC
assay 51Cr-labelled CLA4 target cells,
coated with human anti-HLA serum
(1:500), incubated at 37°C for 3 h with
blood lymphocytes pre-incubated at 37°C
without collagenase for 4 h (*), 16 h (A),
with collagenase for 4h (0), 16h (A)
(see Methods for details).
Natural cytotoxicity assay 51Cr-lab-
elled CLA4 target cells incubated at 37°C
for 24 h with blood lymphocptes pre-
incubated at 37°C without collagenase for
4 h (*), 16 h (A); with collagenase for 4 h
(0), 16 h (A). Enzyme treatment pro-
duces no significant difference in ADCC
and natural cytotoxicity
Passage of blood lymphocytes through
Sephadex G-10 columns did not remove K
and NK cells
To exclude the possibility that the
absence of K and the low NK activity of
the breast-tumour-infiltrating lympho-
cytes was due to the selective retention of
K and NK cells on the Sephadex G-10
column, the ADCC and NK cytotoxicity
of blood lymphocytes before and after
column passage were determined. The
results (Fig. 7) show convincingly that
the Sephadex G-10 column did not selec-
tively remove K and NK cells from the
blood-lymphocyte suspensions. Sephadex
G-10 columns had been shown in a pre-
vious study not to deplete different
lymphocyte subsets (Kanski et al., 1981).
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FIG. 7. Passage of blood lymphocytes down
Sephadex G-10 columns does not reduce
ADCC or natural cytotoxicity. ADCC assay
-51Cr-labelled CLA4 (A) target cells
coated with human anti-HLA serum (1:
500) and 51Cr-labelled Det6 (B) target cells
coated with rat IgG anti-D6 antibody (1:
400) were incubated at 37°C for 3 h with
blood lymphocytes prepared in the stand-
ard manner (@, A)s standard manner and
G-10 column passaged (0, A) (see Meth-
ods for details).
Natural cytotoxicity assay 51Cr-
labelled CLA4 (A) and D6 (B) target cells
were incubated at 37°C for 24 h with blood
lymphocytes prepared in the standard
manner (@*, A); standard manner and
G-10-column passaged (0, A).
G-10-column-passage produced no sig-
nificant difference in ADCC and natural
cytotoxicity.
Suppression of blood K and NK activities
by lymphocyte preparations from breast
tumours
Figs 8, 9 & 10 reveal convincingly that
ADCC and NK cytotoxicity of blood lym-
phocytes could be substantially reduced
by the addition of tumour-infiltrating
lymphocyte preparations. Previous studies
(Eremin et al., 1977b; 1978c) have shown
that the reduction of blood cytotoxicity
in vitro by the addition of certain lympho-
cyte subpopulations was not due to non-
specific factors (e.g. overcrowding) but
to the presence of suppressor or competi-
tive inhibitor cells. In the present study,
the latter cells were not removed by pre-
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FIG. 8.-Lymphocyte preparations from
breast tumours can suppress autologous-
blood ADCC. ADCC assay-5lCr-labelled
CLA4 target cells coated with human anti-
HLA antiserum (1:500), incubated at 37°C
for 3 h with lymphocytes from [(*)
tumour-bearer blood (0) tumour (col-
lagenase-digested see Methods); (0)
Mixture of 0 and 0 in 1:1 ratio; the
lymphocyte: target cell ratio here being
80:1, 40:1 and 0:1. (A) Standard assay.
(B) Pre-incubation of lymphocytes. 37°C
for 24 h before the standard assay.
Statistically significant reduction of
ADCC in (A) and (B) when tumour-infiltra-
ting lymphocyte preparations were added
to patients' blood-lymphoctye suspensions
(P < 0.001).
incubation ofthe lymphocyte preparations
at 37TC on a glass surface in the presence
of 10% foetal calf serum (Figs 8, 9 & 10).
Pretreatment of tumour-infiltrating lym-
phocytes with carbonyl iron was also
unsuccessful (data not shown). The lack
of glass adherence and phagocytosis sug-
gested a non-macrophage-like cell. We
iave preliminary data, however, showing
reduced phagocytic capacity and poor
glass-adherence properties of the macro-
phages within mammary cancers. Thus,
since all the lymphocyte preparations had
a small population of contaminating
tumour macrophages, it was not possible
to determine unequivocally the precise
nature of this "suppressor" cell.
Removal of E-rosetting T lymphocytes fails
to alter the low level ofNK-cell activity
The low level of NK activity in some
preparations of tumour-infiltrating lym-
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FIG. 9. Lymphocyte preparations from
breast tumours suppress autologous-blood
NK activity. Natural cytotoxicity assay-
51Cr-labelled CLA4 target cells incubated
at 370C for 25 h with lymphocyte suspen-
sions prepared as described in Fig. 8.
Statistically significant reduction of
natural cytotoxicity occurred in (A) and
(B) when tumour-infiltrating lymphocyte
preparations were added to patients'
blood-lymphocyte suspensions (P<0.001).
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FIG. 10. As in Fig. 9, using D6 target cells.
phocytes was unaltered by depletion of
the E-rosetting thymus-derived lympho-
cytes (Fig. 11). The T depleted population
was also able to suppress the prominent
NK activity ofthe patients' blood lympho-
cytes. The low levels of cytotoxicity,
therefore, are unlikely to be due to migra-
tion of E-rosetting thymus-derived NK
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FIG. I I. T lymplhocyte is not recsponsible foIr
the low level of NK activity in some lym-
phocyte preparations fiom breastr tumours.
Natural cytotoxicity assay-5lCr-labelled
CLA4 (A, C) and Detroit 6 (B) target cells
incubated at 37°C for 24 h witlh lymplio-
cyte suspensions from (A,) tumour-bearei
blood; tumour (collagenase-digested, Seplo-
adex G-1O-coltumn passaged (0) an(d de-
)letedl of T lymphocytes (C );
tUmour-bearer's bloodl mixe(1 with (0) in
a 1: I ratio; (A) tumour-bearer 's bloodi
mnixe(d witlh (0) in a 1:1 -atio. No altei-a-
tion of NK activity inl (A) an(d (B). Stati.s-
tically significan-t reduction of NK activity
in (C) in both (i ) and (A) (P<0001).
cells from the regional draining lymph
nodes (Eremin etal., 1 978c).
I)ISCUSSION
The present study has revealed that
lymphocytes infiltrating primary mam-
mary carcinomas, in women clinically
assessed as potentially curable, lack K-cell
activity and show low or absent levels of
NK-cell activity. The patients' blood
lymphocytes, on the other hand, possess
variable but prominent ADCC and NK
cytotoxicity.
Several recent studies have reported a
significantly reduced or absent NK-cell
activity in lymphocyte suspensions from
various human solid tumours, including
mammary carcinoma (Vose et al., 1977;
Totterman et al., 1978; Gerson et al.,
1979; Vose & Moore, 1979). The present
investigation thus corroborates and docu-
ments more fully the low levels of natural
cytotoxicity detected in lymphocyte pre-
parations from human mammary car-
cinomas.
In contrast to the findings in man,
tumour-infiltrating lymphocytes isolated
from Moloney sarcoma virus-induced tu-
mours in mice (Becker & Klein, 1976;
Gerson et al., 1979) and methyleholan-
threne-induced sarcomas in rats (Moore &
Moore, 1979) show high levels of natural
cytotoxicity, comparable to that in spleen.
Should this prove to be a consistent find-
ing, it would represent an important and
possibly crucial difference between some
animal tumour models and the common
solid tumours of man.
Very few investigations of ADCC in
lymphocyte suspensions isolated from
human solid tumours have been published.
ADCC has been described in host infiltrat-
ing cells isolated from some animal
tumours. Haskill & Parthenais (1978)
described, using an in vitro colony inhibi-
tion and micro-cytotoxicity assay, mono-
cyte effector cells mediating ADCC, but
they failed to find evidence for the
lymphocytic killer (K) cell.
Investigations have precluded the possi-
bility that the methodology used to isolate
the tumour-infiltrating lymphocytes (col-
lagenase digestion, Sephadex G-10
columns) was responsible for the low level
ofkiller-cell (K and NK) activity detected.
Also, low levels of killer-cell activity were
seen, whatever technique was used to
isolate the tumour-infiltrating lympho-
cytes.
Prolonged washing or incubation at
37°C failed to augment the lytic capacity
of the tumour-infiltrating lymphocytes,
suggesting that receptor blockade was
probably not responsible for the low levels
of cytotoxicity detected. Data from pre-
vious investigations (Eremin et al., 1977b,
1978c) had shown that blockage of the
Fc(IgG) receptor abolished K-cell activity
but had no effect on NK-cell activity.
The present investigation also revealed
that the tumour lymphocyte preparations
were able to reduce substantially the
prominent K and NK activity of the
patients' autologous blood lymphocytes.
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Lymphocytes modulating or "suppressing"
such lytic mechanisms have been recently
described in man (Parkman & Rosen,
1976; Eremin et al., 1977b; Pollack &
Herrick, 1977; Osband & Parkman, 1978).
Removal of adherent or phagocytic cells
had no effect on the inhibitory capacity of
the cell preparations, further suggesting
a lymphocytic suppressor cell. These
procedures, however, never completely
removed all the contaminating macro-
phages, and the lymphocytic nature ofthe
suppressor cell was not established un-
equivocally.
Since the different lymphocyte prepara-
tions from the mammary carcinomas were
contaminated (to a variable degree) by
macrophages and/or breast-tumour cells,
the absent or minimal cytotoxicity detec-
ted in these preparations could possibly
be due to a competitive inhibitory effect
by the "cold" contaminating cells (Ortaldo
et al., 1977; Vose & Moore, 1980). This
possibility was unlikely, however, for the
reasons outlined below.
Firstly, in relation to ADCC, the breast-
tumour cells (assessed morphologically) in
our different preparations lacked surface
immunoglobulin, whilst the macrophage-
acquired immunoglobulin (reacting with
the anti-human Fab reagent) was prob-
ably cytophilically acquired and attached
via the Fe piece. Neither cell would appear
therefore to be a suitable competitor cell
in ADCC, as they lacked the exposed Fc
portion of IgG. This fact was established
by our earlier unpublished findings, show-
ing that the addition of tumour-cell
preparations (not passaged through
Sephadex G-10 and with a very low lym-
phocyte content) to standard ADCC assays
at contaminant or "blocker": target-cell
ratios of 1 :1 to 4:1 had no effect on K-cell
activity. The average contamination by
tumour cells and/or macrophages in our
tumour-lymphocyte preparations was
15%, the contaminant:target-cell ratio
therefore being 3:1 at effector:target-cell
ratios of 20:1, which in most blood
lymphocyte preparations was on the
plateau of maximal lytic activity (see
Fig. iB, C). In some specimens the con-
tamination by non-lymphocytic mono-
nuclear cells was much lower (e.g. 7%), the
"blocker" target-cell ratios now being
3:1 at effector:target-cell ratios of 40:1
(Fig. IA). In all the above experiments,
as well as in virtually all the rest, ADCC
was absent.
Secondly in relation to NK-cell activity,
as can be seen from Figs 3 and 4, where the
contamination by "cold" tumour cells in
all experiments was < 50% and the
"blocker" :target-cell ratio < 2:1 at effec-
tor target-cell ratio of 40:1, the NK
activity was low or absent. In Figs 9B
and 1OB, following preincubation of the
tumour-infiltrating lymphocytes for 24 h,
contamination by breast-tumour cells was
very low (<1%) but inhibition of auto-
logous NK activity was still seen. Previous
studies had shown that the addition of
"cold" tumour cells to standard in vitro
NK-cell assays, using blood lymphocytes
as effector cells, even at "blocker":target-
cell ratios of 4:1, failed to inhibit cyto-
toxicity (unpublished data). These findings
suggest that the low or absent NK activity
of tumour-infiltrating lymphocytes was
not due to competitive inhibition by con-
taminating "cold" tumour cells.
We have previously characterized the
human K and NK cells in blood, and found
them to be IgG Fc-receptor-bearing B
lymphocytes, but lacking a receptor for
the third component of complement
(Fc+ C3-) (Eremin et al., 1977b; 1978c).
The (Fc+ C3+) lymphocyte subpopulation
not only lacked lytic capacity, but could
modulate K and NK activities (Eremin
et al., 1977b, 1978c). A detailed study of
the lymphocyte subpopulations within
breast tumours (Eremin et al., submitted)
has revealed the presence of IgG Fc-
receptor-bearing lymphocytes. Mixed
rosetting reactions revealed, however, a
low level (both in terms of percentage and
absolute numbers) of (Fc+ C3-) lympho-
cytes; i.e., according to our previously
reported findings, a paucity of K and NK
cells and the presence of "suppressor"
lymphocytes.
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Our previous studies have also revealed
that although lymph nodes lack K cells
they have thymus-derived NK cells, in
contrast to the findings in blood (Eremin
et al., 1977b, 1978c). The present investiga-
tion, however, failed to confirm the pre-
sence of such NK cells within the tumour-
cell milieu, and corroborates the evidence
presented in Eremin et al. (submitted)
suggesting an intravascular origin for the
infiltrating lymphocytes.
The lymphocytes within breast tumours
therefore presumably originate from the
intravascular compartment permeating
the growth. Whether the migration of
lymphocytes and particularly K and NK
cells into the tumour substance through
the vascular endothelium is selective and
initiated by immunological factors is
uncertain (Emeson, 1978; Haskill & Par-
thenais, 1978; Radov et al., 1979). Selec-
tive damage oflymphocyte subpopulations
within the tumour, retention and/or
selective proliferation may all be operative
to varying degrees in the complex tumour-
host infiltrative-cell milieu. If ADCC and
NK cytotoxicity do indeed have a host-
defensive role to play (as yet unproven),
the cellular milieu of the tumour is such
as to favour continued tumour growth.
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